AX-0810
/ ProQR
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 18, 2026
PQ-0810-001: A PHASE 1 TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PK, AND PD of AX-0810 IN HEALTHY PARTICIPANTS
(clinicaltrialsregister.eu)
- P1 | N=37 | Recruiting | Sponsor: ProQR Therapeutics VIII B.V.
New P1 trial • Cholestasis • Hepatology
1 to 1
Of
1
Go to page
1